Transcriptomic profiling after B cell depletion reveals central and peripheral immune cell changes in multiple...

Area of Science:

• Immunology
• Neuroscience
• Genetics

Background:

• Multiple sclerosis (MS) is an autoimmune CNS disease.
• B cell depletion is effective for early MS treatment.
• The impact of B cell depletion on the overall immune landscape is not fully understood.

Purpose of the Study:

• To explore immune landscape modulation by B cell-depleting therapies using single-cell RNA-Seq.
• To identify cell-type-specific changes in immune cells following B cell depletion in MS patients.

Main Methods:

• Single-cell RNA sequencing (scRNA-Seq) of immune cells.
• Analysis of cerebrospinal fluid (CSF) and peripheral blood samples.
• Assessment of immune cell abundance, function, and transcriptomic signatures.

Main Results:

• B cell depletion altered CSF macrophages and peripheral monocytes.
• Increased frequency of anti-inflammatory CSF macrophages and CD16+ monocytes observed.
• Changes in CD4+ T cell populations, including TIGIT+ Tregs and reduced myelin-specific T cells.

Conclusions:

• B cell depletion induces significant cell-type-specific reprogramming of the immune system in MS.
• Reveals a detailed transcriptomic map of immunological changes post-treatment.
• Provides insights into the mechanisms underlying B cell depletion therapy in MS.